A recent bioinformatic study suggests that the implication of Tau in cancer is likely mediated by modulation of three main pathways: epithelial-to-mesenchymal transition (EMT), inflammation, and regulation of the cell cycle [27]. The gene discussed is MAPT; the disease is cancer.